FilingReader Intelligence
Natco Pharma acquires 35.75% stake in Adcock Ingram
July 29, 2025 at 11:19 AM UTC•By FilingReader AI
Natco Pharma Limited acquired a 35.75% stake in Adcock Ingram Holdings Limited for approximately INR 2,000 crores, marking the company's largest investment to date.
Adcock Ingram reported annualized revenue exceeding $500 million last year. The acquisition aims to expand Natco's global presence in the African pharmaceutical market and could push the group's revenue to nearly $1 billion.
Natco Pharma intends to delist Adcock Ingram, making it a private holding company.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:NATCOPHARM•Bombay Stock Exchange
News Alerts
Get instant email alerts when Natco Pharma publishes news
Free account required • Unsubscribe anytime